Vivo Bio Tech Ltd. Stock Analysis 511509.BO

Vivo Bio Tech Ltd. engages in the provision of drug development and discovery services. The company operates in the biotechnology segment. The company provides integrated discovery, development & regulatory services to pharmaceutical, agrochemical, industrial chemical, vaccines, nutraceutical & medical device companies. The firm's services include in-Vivo and in-Vitro toxicity studies, pharmacological investigations, pharmacokinetic, toxicokinetic studies, genotoxicity screening and analytical services. The company screens and assesses molecules for diverse pharmacological properties. In oncology, it designs syngeneic/xenograft models for anti-cancer agent evaluation. The company customizes in-Vivo DMPK studies for rodent and non-rodent models to profile drug candidates. The company provides both regulatory and non-regulatory IND-enabling preclinical development services.